Literature DB >> 22749703

Patient satisfaction following Bio-Alcamid injection for facial contour defects.

D A George1, E Erel, R Waters.   

Abstract

Bio-Alcamid, a polyalkylimide gel, can be injected into subcutaneous tissue as an endoprosthesis for correcting contour deformities and soft tissue defects. We have reviewed its facial uses and longer-term outcomes over a 7-year period, including a patient satisfaction survey. 69 patients were included in the study, 89.9% undergoing treatment secondary to HIV-associated facial lipoatrophy. 55.0% of patients responded to questionnaires: 52.5% experienced severe pain associated with injections, and 50.0% experienced at least one complication (migration, hardening, irregularity). 94.4% stated an improvement in their cheek volume, 77.8% would undergo the procedure again, and 86.1% would recommend the treatment to a friend. Despite the relatively high patient satisfaction, we no longer recommend this treatment to our patients for cosmetic indications, due to significant long-term complication rates.
Copyright © 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749703     DOI: 10.1016/j.bjps.2012.06.017

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  1 in total

1.  Long-term outcomes of surgically removed migrated polyalkylimide (bio-alcamid) filler to the periorbital area.

Authors:  Ziyad A AlHarbi; Hind M Alkatan; Adel H Alsuhaibani
Journal:  Saudi J Ophthalmol       Date:  2019-07-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.